Shuoshi Biotech (688399.SH) disclosed its 2023 annual report. The company achieved operating income of 4 during the reporting period...
According to Zhitong Finance App News, Shuoshi Biotech (688399.SH) disclosed its 2023 annual report. The company achieved operating revenue of 403 million yuan during the reporting period, a year-on-year decrease of 92.72%. The net loss attributable to shareholders of the listed company was 374 million yuan, and the net loss attributable to shareholders of the listed company after deducting non-recurring profit and loss was 429 million yuan, which changed from profit to loss over the previous year.